P504 has direct interactions with the ligand and it is involved in all interaction sites of the SSD (Supplementary Figure S1), and the mutant PTCH1-P504L may result in Gorlin syndrome (Boutet et al., 2003). Here, PTCH1 is linked to nevoid basal cell carcinoma syndrome.